SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19

SARS-CoV-2 antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike IgG titers compared to those with severe coronavirus disease 2019 (COVID-19), likely reflecting a lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Elizabeth M., Diorio, Caroline, Goodwin, Eileen C., McNerney, Kevin O., Weirick, Madison E., Gouma, Sigrid, Bolton, Marcus J., Arevalo, Claudia P., Chase, Julie, Hicks, Philip, Manzoni, Tomaz B., Baxter, Amy E., Andrea, Kurt P., Burudpakdee, Chakkapong, Lee, Jessica H., Vella, Laura A., Henrickson, Sarah E., Harris, Rebecca M., Wherry, E. John, Bates, Paul, Bassiri, Hamid, Behrens, Edward M., Teachey, David T., Hensley, Scott E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444298/
https://www.ncbi.nlm.nih.gov/pubmed/32839782
http://dx.doi.org/10.1101/2020.08.17.20176552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444298/
https://www.ncbi.nlm.nih.gov/pubmed/32839782
http://dx.doi.org/10.1101/2020.08.17.20176552

Ejemplares similares